Takeda Pharmaceutical Company Limited
4502
Pozycja w akcjach
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Cena akcji
$40.45
Kapitalizacja rynkowa
$64.36B
Zmiana (1 dzień)
1.19%
Zmiana (1 rok)
43.11%
Kraj
JP
Handel Takeda Pharmaceutical Company Limited (4502)
Kategoria
Healthcare
Historia ceny akcji dla Takeda Pharmaceutical Company Limited (4502)
Najwyższa cena zamknięcia: $38.84 dnia 2026-10-01
Najniższa cena zamknięcia: $15.37 dnia 1990-01-01
Najniższa cena zamknięcia: $15.37 dnia 1990-01-01
Historia cen akcji firmy Takeda Pharmaceutical Company Limited od 1990 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 16.58% |
| 2025 | 9.81% |
| 2024 | -4.74% |
| 2023 | -6.93% |
| 2022 | 10.67% |
| 2021 | -25.73% |
| 2020 | -8.85% |
| 2019 | 17.44% |
| 2018 | -38.14% |
| 2017 | 35.62% |
| 2016 | -15.67% |
| 2015 | 15.94% |
| 2014 | -13.88% |
| 2013 | 6.22% |
| 2012 | 10.14% |
| 2011 | -12.31% |
| 2010 | 13.40% |
| 2009 | -15.52% |
| 2008 | -16.70% |
| 2007 | -10.91% |
| 2006 | 20.85% |
| 2005 | 12.27% |
| 2004 | 25.62% |
| 2003 | -3.39% |
| 2002 | -8.53% |
| 2001 | -25.89% |
| 2000 | 8.44% |
| 1999 | 100.05% |
| 1998 | 14.68% |
| 1997 | 57.21% |
| 1996 | 45.92% |
| 1995 | 33.20% |
| 1994 | 4.32% |
| 1993 | -8.10% |
| 1992 | -2.51% |
| 1991 | -23.26% |
| 1990 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $212.49 | 24.09% |
CH
|
|
| $6.98 | -23.78% |
CN
|
|
| $18.41 | -4.14% |
IN
|
